Endovascular Therapy for Cerebral Vein Thrombosis: A Propensity-Matched Analysis of Anticoagulation in the Treatment of Cerebral Venous Thrombosis.

Publikation

Endovascular Therapy for Cerebral Vein Thrombosis: A Propensity-Matched Analysis of Anticoagulation in the Treatment of Cerebral Venous Thrombosis.

Wissenschaftlicher Artikel/Review - 23.08.2022

Siegler James, Shu Liqi, Yaghi Shadi, Omran Setareh Salehi, Elnazeir Marwa, Bakradze Ekaterina, Psychogios Marios-Nikos, De Marchis Gian Marco, Yu Siyuan, Klein Piers, Abdalkader Mohamad, Nguyen Thanh N, ACTION-CVT Investigators

Zitation

Siegler J, Shu L, Yaghi S, Omran S, Elnazeir M, Bakradze E, Psychogios M, De Marchis G, Yu S, Klein P, Abdalkader M, Nguyen T, ACTION-CVT Investigators. Endovascular Therapy for Cerebral Vein Thrombosis: A Propensity-Matched Analysis of Anticoagulation in the Treatment of Cerebral Venous Thrombosis. Neurosurgery 2022; 91:749-755.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Neurosurgery 2022; 91

Veröffentlichungsdatum

23.08.2022

eISSN (Online)

1524-4040

Seiten

749-755

Kurzbeschreibung/Zielsetzung

Endovascular treatment (EVT) for cerebral vein thrombosis (CVT) has not been proven to be more effective than anticoagulation based on recent results of the Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis (TO-ACT) randomized clinical trial.